Your TFDA Gateway

Why Thailand Strategic Market Position in ASEAN's Pharmaceutical Landscape Major ASEAN Economic Hub

Thailand is one of the larger economies within ASEAN and has been an active participant in the regional economic and political landscape. Thailand's pharmaceutical market, valued at around 188 billion Thai baht or $6.4 billion, is a very attractive market for pharmaceutical companies.

The Thai FDA, under the Ministry of Public Health, regulates the market with comprehensive oversight ensuring:

Foreign pharmaceutical companies looking to register their products in Thailand must appoint a local representative to facilitate communication with the TFDA and ensure compliance with all regulatory requirements.

Identifying a reliable and qualified local representative can be a crucial factor to the successful registration with TFDA.

Regulatory policies in Thailand are constantly being updated, impacting the drug registration process. Companies need to stay abreast of any policy changes and adapt their strategies accordingly.

Despite the regulatory complexities, the market is expected to grow due to several key factors:

Over 10 years of experience in Regulatory Affairs.

Successfully registered over 5 New Drug Applications (NDAs) in Thailand within the past 5 years, encompassing diverse therapeutic areas such as small molecules, vaccines, and biologics. Beside new drug, we experienced in registering various product categories, including generic drug, animal drug, herbal drug, cosmetics, health supplements, medical devices, food supplements.

Provided comprehensive life-cycle management support, including variations and pharmacovigilance services.

Managed Thai FDA Good Manufacturing Practices (GMP) Clearance applications for foreign manufacturing sites.

Provided in-depth regulatory intelligence reports that significantly contributed to the successful market entry.

Facilitated submission consultations with the Thai FDA, resulting in successful resolution of regulatory queries and expedited product approval timelines.

Do not let Thailand's regulatory complexities delay your market entry. Our Thailand-based regulatory experts, serving as your qualified local representative with deep TFDA knowledge, are ready to accelerate your pharmaceutical registration in this attractive $6.4 billion market with significant growth potential.

to discuss how our Thailand expertise can unlock opportunities in one of ASEAN's largest pharmaceutical markets.

Thai drug facility licenses cover sales, manufacturing, and import establishments. Applicants must meet legal-entity rules—and foreign players the Alien Business Operations Act—while keeping a pharmacist present and GMDP/GDP/GPP practices alive every day.

Overseas plants need GMP Clearance. Our import establishment is already licensed in Thailand; we keep tightening compliance so partners inherit an operational base, not a paper plan.

The Thai FDA under the Ministry of Public Health evaluates and approves pharmaceutical products against safety, quality, and efficacy standards before local marketing.

Drug Act, B.E.2510 (1967) and its amendments

Ministerial notification on drug registration

Thai registration rewards teams that respect the calendar. ICH eCTD documents, SKYNET item lists, Docubridge or THAIRIMS uploads, and Form Yor.1 are only the start—screening and evaluation fees each have hard 30-day windows that can kill an application if ignored.

Our team documents assumptions, authority expectations, and decision points so sponsors can approve the plan with clear risk ownership.

Local pharmacists and regulatory specialists stay accountable through query cycles, inspection readiness, and post-approval obligations.

We align labeling, Module 1 localization, and partner communications so commercial launch can follow approval without rework.

Where pathways differ by product class, we sequence filings to protect the critical path and avoid avoidable deficiency letters.

Engagements can scale from a single dossier workstream to a multi-country virtual regulatory function.

PECAN.Solutions scopes each workstream with milestones, document owners, and authority touchpoints so registration, license holding, and commercial access stay on one plan.

Our team documents assumptions, authority expectations, and decision points so sponsors can approve the plan with clear risk ownership.

Local pharmacists and regulatory specialists stay accountable through query cycles, inspection readiness, and post-approval obligations.